50mg Tigebax Tigecycline Injection IP

Description

Tigebax 50 mg Injection (Tigecycline IP) contains tigecycline, a broad-spectrum antibiotic used to treat serious bacterial infections, including complicated skin and soft tissue infections, intra-abdominal infections, and community-acquired pneumonia. It works by inhibiting bacterial protein synthesis, stopping the growth of susceptible bacteria. The injection is administered intravenously under medical supervision, usually in hospital settings. Tigebax is reserved for infections that are resistant to other antibiotics. It must be used under strict medical supervision due to possible side effects.